Trial
NCT07011771
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Capsida Biotherapeutics, Inc.
Collaborators
—
Condition
GBA1 Parkinson Disease
Intervention
gene therapy
Why stopped
Per protocol stopping rule was met for a separate trial for a different disease state and different experimental therapy that utilized a similar technology.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22